EU MDR · Ortho · PMCF

PMCF for orthopedic devices, built on the registries.

Orthopedics has something most specialties lack: mature national implant registries. Used well, they make PMCF efficient. Here is how to build long-term ortho evidence.

EU MDR 2017/745NJR / EPRD / SwespineRegistry RWERevision rate
PMCF for orthopaedic devices with registries, Eclevar MedTech

European Champion

Platinum Award 2026

Eclevar MedTech & Milo Health · xShare × EUCROF Open Call

Led by authority

Ortho PMCF, led by an ortho reviewer.

Orthopedic PMCF is a specialty in itself. Ours is led by a former Notified Body reviewer for Class III implants.

Dr Nikhil Khadabadi

Dr Nikhil Khadabadi

CMO, Ortho & Spine · former TÜV SÜD reviewer

Former Notified Body assessor for Class III implants; PMCF and CER methodology, ortho and high-risk devices.

in LinkedIn
Sébastien Meier

Sébastien Meier

Chief Data Officer · Biometry · 30 yrs

Endpoints, statistics and RWE; architect of the MILO EDC, 21 CFR Part 11 and real-time dashboards.

EU MDR 2017/745Registry RWENJR / EPRDOrtho & spine

Awards, funding, accountability

Europe’s best-rated medical device CRO.

Platinum Award 2026

Platinum Award 2026

Top tier at the xShare × EUCROF Open Call, awarded to Eclevar MedTech and its Milo Health platform, presented at EUCROF 2026 in Amsterdam.

The announcement →

Co-funded by the European Union

Selected through the xShare Open Call for clinical research innovation, Horizon Europe.

xShare results →

Independently reported

Distinction confirmed by an independent third party, the CVBF, also an awardee of the xShare × EUCROF Open Call.

CVBF coverage →

The strategy

Why run a trial when the registry already has the data?

National implant registries capture revision and survivorship data at a scale no single study can match. The art of ortho PMCF is using them well, and knowing when they are not enough.

01

The registry advantage

Registries like the NJR (UK), EPRD (Germany) and Swespine capture large-scale, long-term outcome data, above all implant survivorship and revision rates. For many hip, knee and spine devices, registry data is the most efficient route to the real-world evidence PMCF requires.

02

Where registries fall short

Registries are powerful but not complete.

When registry data is not enough

  • Novel devices with too little registry exposure yet
  • Endpoints registries do not capture (function, PROs, imaging)
  • Specific claims needing controlled comparison
  • Early signals needing prospective confirmation

03

The hybrid PMCF design

The strongest ortho PMCF blends both: registry data for survivorship and revision at scale, and a lean prospective observational study or PRO survey for function and patient-reported outcomes the registry misses. Each covers the other’s blind spot.

04

Making it Notified-Body-ready

Whatever the mix, the PMCF plan must tie each data source to a specific evidence gap in the CER, so a reviewer can see why registry data answers one question and a study answers another. We design the plan so it survives the technical file audit.

Ortho PMCF

Registry plus study.

NJR / EPRD
survivorship at scale
Revision rate
the headline endpoint
PROs
what registries miss
Hybrid
the strongest design

Talk to a specialist

What is the leanest PMCF for your orthopedic device?

Book a free scoping call with a former Notified Body ortho reviewer. We design a registry-plus-study PMCF matched to your claims.

Book a free scoping call

For orthopedics, the registry is your PMCF head start.

An expert read designs a registry-plus-study PMCF matched to your device and claims, so you get robust evidence without over-building the study.

Book a free scoping call

Questions we hear first

Orthopedic PMCF, answered.

Why are registries so useful for orthopedic PMCF?
National implant registries such as the NJR, EPRD and Swespine capture large-scale, long-term implant survivorship and revision data that no single study can match, making them the most efficient route to real-world evidence for many hip, knee and spine devices.
When is registry data not enough?
For novel devices with limited registry exposure, endpoints registries do not capture such as function, PROs and imaging, specific claims needing controlled comparison, or early signals needing prospective confirmation.
What is a hybrid PMCF design?
It combines registry data for survivorship and revision at scale with a lean prospective observational study or PRO survey for function and patient-reported outcomes the registry misses, so each source covers the other’s blind spot.
How do you make ortho PMCF Notified-Body-ready?
By tying each data source in the PMCF plan to a specific evidence gap in the CER, so a reviewer can see why registry data answers one question and a study answers another, and the plan survives the technical file audit.

Reforming Clinical Evaluation of Medical Devices in Europe